Update on pharmacotherapy guidelines for the treatment of neuropathic pain

被引：26

作者：

Dobecki D.A. ^{[1
]}

Schocket S.M. ^{[1
]}

Wallace M.S. ^{[1
]}

机构：

[1] Center for Pain and Palliative Medicine, University of California, San Diego, La Jolla, CA 92093

来源：

Current Pain and Headache Reports | 2006年 / 10卷 / 3期

关键词：

Neuropathic Pain; Gabapentin; Tramadol; Venlafaxine; Pregabalin;

D O I：

10.1007/s11916-006-0044-9

中图分类号：

学科分类号：

摘要：

Neuropathic pain is a common problem in our society affecting nearly 1.5% of the US population. There currently are five medications approved by the US Food and Drug Administration (FDA) for the treatment of neuropathic pain, which include gabapentin, pregabalin, duloxetine, 5% lidocaine patch, and carbamazepine. Other agents with proven efficacy in multiple randomized, placebo-controlled trials include opioids, tricyclic antidepressants, venlafaxine, and tramadol. All of these agents, both FDA-approved and off-label, have been recommended as first-line treatments for neuropathic pain. This article discusses these agents in detail as they relate to the treatment of neuropathic pain. Copyright © 2006 by Current Science Inc.

引用

页码：185 / 190

页数：5

共 38 条

[1]

Bennett G.J., Neuropathic pain: New insights, new interventions, Hosp Pract, 33, pp. 107-110, (1998)

[2]

Dworkin R.H., Backonja M., Rowbotham M.C., Et al., Advances in neuropathic pain: Diagnosis, mechanisms, and treatment recommendations, Arch Neurol, 60, pp. 1524-1534, (2003)

[3]

Sindrup S.H., Jensen T.S., Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action, Pain, 83, pp. 389-400, (1999)

[4]

O'Connor A.B., Dworkin R.H., Chronic neuropathic pain and advances in its treatment, Prog in Neuropathic Pain, 2005, pp. 19-30

[5]

L.p.C.C.p., Data on file, (2005)

[6]

Randinitis E.J., Posvar E.L., Alvey C.W., Et al., Pharmacokinetics of pregabalin in subjects with various degrees of renal function, J Clin Pharmacol, 43, pp. 277-283, (2003)

[7]

Dworkin R.H., Corbin A.E., Young Jr. J.P., Et al., Pregabalin for the treatment of postherpetic neuralgia: A randomized, placebo-controlled trial, Neurology, 60, pp. 1274-1288, (2003)

[8]

Sabatowski R., Galvez R., Cherry D.A., Et al., Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: Results of a randomised, placebo-controlled clinical trial, Pain, 109, pp. 26-35, (2004)

[9]

Rosenstock J., Tuchman M., LaMoreaux L., Sharma U., Et al., Pregabalin for the treatment of painful diabetic peripheral neuropathy: A double-blind, placebo-controlled trial, Pain, 110, pp. 628-638, (2004)

[10]

Lesser H., Sharma U., LaMoreaux L., Poole R.M., Et al., Pregabalin relieves symptoms of painful diabetic neuropathy: A randomized, controlled trial, Neurology, 63, pp. 2104-2110, (2004)

← 1 2 3 4 →